Literature DB >> 17693522

Characterization and biological role of the O-polysaccharide gene cluster of Yersinia enterocolitica serotype O:9.

Mikael Skurnik1, Marta Biedzka-Sarek, Peter S Lübeck, Tea Blom, José Antonio Bengoechea, Camino Pérez-Gutiérrez, Peter Ahrens, Jeffrey Hoorfar.   

Abstract

Yersinia enterocolitica serotype O:9 is a gram-negative enteropathogen that infects animals and humans. The role of lipopolysaccharide (LPS) in Y. enterocolitica O:9 pathogenesis, however, remains unclear. The O:9 LPS consists of lipid A to which is linked the inner core oligosaccharide, serving as an attachment site for both the outer core (OC) hexasaccharide and the O-polysaccharide (OPS; a homopolymer of N-formylperosamine). In this work, we cloned the OPS gene cluster of O:9 and identified 12 genes organized into four operons upstream of the gnd gene. Ten genes were predicted to encode glycosyltransferases, the ATP-binding cassette polysaccharide translocators, or enzymes required for the biosynthesis of GDP-N-formylperosamine. The two remaining genes within the OPS gene cluster, galF and galU, were not ascribed a clear function in OPS biosynthesis; however, the latter gene appeared to be essential for O:9. The biological functions of O:9 OPS and OC were studied using isogenic mutants lacking one or both of these LPS parts. We showed that OPS and OC confer resistance to human complement and polymyxin B; the OPS effect on polymyxin B resistance could be observed only in the absence of OC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693522      PMCID: PMC2168460          DOI: 10.1128/JB.00605-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  61 in total

1.  A real-time PCR assay for the specific identification of serotype O:9 of Yersinia enterocolitica.

Authors:  N R Jacobsen; T Bogdanovich; M Skurnik; P S Lübeck; P Ahrens; J Hoorfar
Journal:  J Microbiol Methods       Date:  2005-04-19       Impact factor: 2.363

2.  Enzyme-linked immunosorbent assay for differentiation of the antibody response of cattle naturally infected with Brucella abortus or vaccinated with strain 19.

Authors:  K Nielsen; J W Cherwonogrodzky; J R Duncan; D R Bundle
Journal:  Am J Vet Res       Date:  1989-01       Impact factor: 1.156

3.  Yersiniophage phiR1-37 is a tailed bacteriophage having a 270 kb DNA genome with thymidine replaced by deoxyuridine.

Authors:  Saija Kiljunen; Kristo Hakala; Elise Pinta; Suvi Huttunen; Patrycja Pluta; Aneta Gador; Harri Lönnberg; Mikael Skurnik
Journal:  Microbiology       Date:  2005-12       Impact factor: 2.777

4.  The structure of the carbohydrate backbone of the core-lipid A region of the lipopolysaccharide from a clinical isolate of Yersinia enterocolitica O:9.

Authors:  S Müller-Loennies; S Rund; E Ervelä; M Skurnik; O Holst
Journal:  Eur J Biochem       Date:  1999-04

5.  Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B.

Authors:  Andrey P Anisimov; Svetlana V Dentovskaya; Galina M Titareva; Irina V Bakhteeva; Rima Z Shaikhutdinova; Sergey V Balakhonov; Buko Lindner; Nina A Kocharova; Sof'ya N Senchenkova; Otto Holst; Gerald B Pier; Yuriy A Knirel
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

6.  Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9.

Authors:  M Caroff; D R Bundle; M B Perry
Journal:  Eur J Biochem       Date:  1984-02-15

7.  A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo.

Authors:  Slade A Loutet; Ronald S Flannagan; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

8.  Lipopolysaccharide O antigen status of Yersinia enterocolitica O:8 is essential for virulence and absence of O antigen affects the expression of other Yersinia virulence factors.

Authors:  José Antonio Bengoechea; Hristo Najdenski; Mikael Skurnik
Journal:  Mol Microbiol       Date:  2004-04       Impact factor: 3.501

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Role of YadA in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats.

Authors:  C Gripenberg-Lerche; M Skurnik; L Zhang; K O Söderström; P Toivanen
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more
  11 in total

1.  Characterization of the six glycosyltransferases involved in the biosynthesis of Yersinia enterocolitica serotype O:3 lipopolysaccharide outer core.

Authors:  Elise Pinta; Katarzyna Anna Duda; Anna Hanuszkiewicz; Tiina A Salminen; José Antonio Bengoechea; Heidi Hyytiäinen; Buko Lindner; Joanna Radziejewska-Lebrecht; Otto Holst; Mikael Skurnik
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

2.  A transposon site hybridization screen identifies galU and wecBC as important for survival of Yersinia pestis in murine macrophages.

Authors:  Kathryn A Klein; Hana S Fukuto; Mark Pelletier; Galina Romanov; Jens P Grabenstein; Lance E Palmer; Robert Ernst; James B Bliska
Journal:  J Bacteriol       Date:  2011-12-02       Impact factor: 3.490

3.  Trimer stability of YadA is critical for virulence of Yersinia enterocolitica.

Authors:  M Schütz; E-M Weiss; M Schindler; T Hallström; P F Zipfel; D Linke; I B Autenrieth
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

4.  Spontaneous excision of the O-polysaccharide wbkA glycosyltranferase gene is a cause of dissociation of smooth to rough Brucella colonies.

Authors:  Marcos Mancilla; Clara M Marín; José M Blasco; Ana María Zárraga; Ignacio López-Goñi; Ignacio Moriyón
Journal:  J Bacteriol       Date:  2012-02-10       Impact factor: 3.490

5.  O antigen protects Bordetella parapertussis from complement.

Authors:  Elizabeth M Goebel; Daniel N Wolfe; Kelly Elder; Scott Stibitz; Eric T Harvill
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

6.  Shotgun sequencing of Yersinia enterocolitica strain W22703 (biotype 2, serotype O:9): genomic evidence for oscillation between invertebrates and mammals.

Authors:  Thilo M Fuchs; Katharina Brandt; Mandy Starke; Thomas Rattei
Journal:  BMC Genomics       Date:  2011-03-31       Impact factor: 3.969

7.  Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis.

Authors:  Jeremy A Iwashkiw; Messele A Fentabil; Amirreza Faridmoayer; Dominic C Mills; Mark Peppler; Cecilia Czibener; Andres E Ciocchini; Diego J Comerci; Juan E Ugalde; Mario F Feldman
Journal:  Microb Cell Fact       Date:  2012-01-25       Impact factor: 5.328

8.  A protein-conjugate approach to develop a monoclonal antibody-based antigen detection test for the diagnosis of human brucellosis.

Authors:  Kailash P Patra; Mayuko Saito; Vidya L Atluri; Hortensia G Rolán; Briana Young; Tobias Kerrinnes; Henk Smits; Jessica N Ricaldi; Eduardo Gotuzzo; Robert H Gilman; Renee M Tsolis; Joseph M Vinetz
Journal:  PLoS Negl Trop Dis       Date:  2014-06-05

9.  Regulatory protein OmpR influences the serum resistance of Yersinia enterocolitica O:9 by modifying the structure of the outer membrane.

Authors:  Karolina Skorek; Adrianna Raczkowska; Bartłomiej Dudek; Katarzyna Miętka; Katarzyna Guz-Regner; Aleksandra Pawlak; Elżbieta Klausa; Gabriela Bugla-Płoskońska; Katarzyna Brzostek
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

10.  The Role of OmpR in the Expression of Genes of the KdgR Regulon Involved in the Uptake and Depolymerization of Oligogalacturonides in Yersinia enterocolitica.

Authors:  Marta Nieckarz; Adrianna Raczkowska; Karolina Jaworska; Ewa Stefańska; Karolina Skorek; Dorota Stosio; Katarzyna Brzostek
Journal:  Front Cell Infect Microbiol       Date:  2017-08-15       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.